The E3 ubiquitin ligase HECTD3 controls immune colonic inflammation by restricting MyD88 activation and signaling
JCI Insight · 2026
DOI: 10.1172/jci.insight.185437 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2026. Verfasst von Shamima Islam und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. Hauptthemen laut MEDLINE: Myeloid Differentiation Factor 88, Ubiquitin-Protein Ligases, Colon, Colitis, Ulcerative. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIDDK NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Ubiquitination is an important posttranslational modification associated with essential cellular processes. Here we show that deletion of E3 ubiquitin ligase HECTD3 — germline or in hematopoietic compartment, including in Cd11c + cells — causes severe disease and increased production of proinflammatory cytokines in a murine model of ulcerative colitis (UC). HECTD3 mRNA levels were found reduced in colonic tissues of patients with UC, which highlights a potential role for HECTD3 in regulating inflammatory responses in UC. We identified MyD88, a central adaptor in the TLR/IL-1R signaling and inflammatory response, as a target for HECTD3 ubiquitination. We demonstrate that HECTD3 ubiquitinates MyD88 through K27-linked Poly-Ub chains in a nondegradative manner. HECTD3-KO GM-CSF–bone marrow–derived cells treated with the TLR4 ligand LPS produced more proinflammatory cytokines, showed elevated phosphorylation of NF-κB and IRAK4, as well as increased association of MyD88 with IRAK4, demonstrating that HECTD3 controls MyD88/IRAK4/NF-κB axis. Inhibition of MyD88 activity rescued colitis severity in the HECTD3-KO mice, including the elevated proinflammatory cytokine production. Thus, our results establish MyD88 as a target for HECTD3 nondegradative polyubiquitination and restriction of innate immune colonic inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
- Department of Anatomy and Cell Biology, College of Medicine, University of Florida, Gainesville, Florida, USA.
- Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
- J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, Florida, USA.
- Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, Department of Chemistry and Biochemistry, College of Science & College of Medicine, The BIO5 Institute, The University of Arizona, Tucson, Ariz…
- Taplin Mass Spectrometry Facility, Harvard Medical School, Boston, Massachusetts, USA.
Förderung
- NINDS NIH HHS
- NIDDK NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- NIAID NIH HHS
Zitieren
APA
Islam, S., Mannan, S., Zuniga, A., Parthasarathy, U., Cismasiu, V. B., Silvane, L., Chakraborty, S., Talada, D. P., Singh, R. P., Zelenka, T., Naveen, A., Vickers, S. C., Grant, M. G., Cho, J. J., Drashansky, T., Kwiatkowski, A. J., Liu, X., Tomaino, R., Guryanova, O. A., …, & Avram, D. (2026). The E3 ubiquitin ligase HECTD3 controls immune colonic inflammation by restricting MyD88 activation and signaling. JCI Insight. https://doi.org/10.1172/jci.insight.185437
Vancouver
Islam S, Mannan S, Zuniga A, Parthasarathy U, Cismasiu VB, Silvane L, et al. The E3 ubiquitin ligase HECTD3 controls immune colonic inflammation by restricting MyD88 activation and signaling. JCI Insight. 2026. doi:10.1172/jci.insight.185437
BibTeX
@article{Islam2026,
author = {Islam, Shamima and Mannan, Shahnewaj and Zuniga, Ashley and Parthasarathy, Upasana and Cismasiu, Valeriu B and Silvane, Leonardo and Chakraborty, Sayan and Talada, Divya Priyanka and Singh, Raghwendra Pratap and Zelenka, Tomas and Naveen, Amreen and Vickers, Sephra Chyanne and Grant, Michael Gm and Cho, Jonathan J and Drashansky, Theodore and Kwiatkowski, Alexander J and Liu, Xintong and Tomaino, Ross and Guryanova, Olga A and Ferraro, Mariola J and Kim, Sang Yong and Jobin, Christian and Keselowsky, Benjamin G and Li, Hongmin and Rodriguez, Paulo C and Molgora, Martina and Beg, Amer A and Shaw, Timothy I and Ruan, Zheng and Wan, Lixin and Avram, Dorina},
title = {The E3 ubiquitin ligase HECTD3 controls immune colonic inflammation by restricting MyD88 activation and signaling},
journal = {JCI Insight},
year = {2026},
doi = {10.1172/jci.insight.185437}
}
EUVIMED